Immunometabolic Dysregulation in Psoriasis: Mechanisms Driving Inflammation and Emerging Therapeutic Targets
Targeting immunometabolic pathways through glycolysis inhibitors, AMPK activators, mTOR modulators, mitochondrial-targeted antioxidants, and lipid-regulating agents may restore metabolic homeostasis and reduce inflammation. Advances in multi-omics approaches may further facilitate biomarker discovery and precision-based therapeutic strategies in psoriasis management.
Authors
- Preeti Patel (ORCID: https://orcid.org/0000-0001-8708-630X)
- Balak Das Kurmi (ORCID: https://orcid.org/0000-0001-8470-6622)
- Aman Kumar
- Aditya Jaswal
Institutions
- Indo Soviet Friendship College of Pharmacy (IN)
Publication Details
- Journal
- Immunological Investigations
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1080/08820139.2026.2645963
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00